+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

CSF penetration and pharmacokinetics of midazolam



CSF penetration and pharmacokinetics of midazolam



European Journal of Clinical Pharmacology 25(2): 247-251




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 042429338

Download citation: RISBibTeXText

PMID: 6628509

DOI: 10.1007/bf00543799


Related references

Impact of nonlinear midazolam pharmacokinetics on the magnitude of the midazolam-ketoconazole interaction in rats. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 42(11): 1058-1068, 2013

Pharmacokinetics of midazolam and alpha-hydroxy-midazolam following rectal and intravenous administration. British Journal of Clinical Pharmacology 25(4): 457-463, 1988

Pharmacokinetics of midazolam and metabolites in a patient with refractory status epilepticus treated with extraordinary doses of midazolam. Therapeutic Drug Monitoring 30(1): 120-124, 2008

Population pharmacokinetic modeling in very premature infants receiving midazolam during mechanical ventilation: midazolam neonatal pharmacokinetics. Anesthesiology 90(2): 451-457, 1999

Pharmacokinetics of intravenous midazolam and 1-OH-midazolam in preterm infants. Pediatric Research 49(4 Part 2): 454A, April, 2001

Pharmacokinetics of oral midazolam and 1-OH-midazolam in preterm infants. Clinical Pharmacology & Therapeutics 69(2): P20, February, 2001

Pharmacokinetics of IV midazolam and 1-OH-midazolam in preterm infants. Clinical Pharmacology & Therapeutics 69(2): P20, February, 2001

The pharmacokinetics of ketoconazole and its effects on the pharmacokinetics of midazolam and fentanyl in dogs. Journal of Veterinary Pharmacology and Therapeutics 33(1): 42-49, 2010

Pharmacokinetics and bioavailability of midazolam after intravenous, subcutaneous, intraperitoneal and oral administration under a chronic food-limited regimen: Relating DRL performance to pharmacokinetics. Psychopharmacology 126(3): 241-248, 1996

A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics. Anesthesia and Analgesia 115(2): 274-283, 2012

Midazolam pharmacokinetics. Critical Care Medicine 21(12): 1979-1981, 1993

Pharmacokinetics of midazolam in man. Der Anaesthesist 30(6): 280-283, 1981

The pharmacokinetics of midazolam in man. European Journal of Clinical Pharmacology 19(4): 271-278, 1981